Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether ipilimumab given with paclitaxel/carboplatin
has clinical benefit when compared with paclitaxel/carboplatin alone in patients with
previously untreated lung cancer.